Mashup Score:100
JAMA NetworkTwitter Feed: Sek Kathiresan MD
Mashup Score:50
peppinosdosa.comPeppino’s Dosa - 1 month
Mashup Score:50
Gluten Free, Vegan, 100% Vegetarian Pizza, Pasta, Fresh Salads, Homemade Vegan Nice Cream, Fresh Juice Bar, with our own sauces, pestos and homemade...
-
Christmas Eve lunch Dosa, of course. 😊 https://t.co/y2tnZ76Ka5 Waltham, MA https://t.co/y2tnZ76Ka5 - view on twitter
Mashup Score:30
OUP Academicyear in cardiovascular medicine 2022: the top 10 papers in dyslipidaemias - 3 weeks
Mashup Score:30
The lipid-lowering landscape is rapidly evolving and several trials published this year provided new insights. The CORDIOPREV Trial was a Spanish single...
-
Nice graphical abstract from @escardio review on advances in dyslipidemia (L) @vervetx mission (R) Three pillars of lipoprotein risk - LDL, TRL, Lp(a) We are developing a once-&-done medicine for each: PCSK9 (LDL), ANGPTL3 (LDL & TRL), and LPA (Lp(a)) https://t.co/XAYmJXUNw0 https://t.co/XAYmJXUNw0 - view on twitter
Mashup Score:25
NatureAcademia’s lost luster prompts exodus of health researchers to industry - 3 weeks
Mashup Score:25
A desire for better work conditions and real-world impact are behind the movement, which may hinder academic clinical trials while leading to beneficial...
-
Deeply researched piece by @clarewhatson for @NatureMedicine “Might I be better off — might the world be better off — with me doing something different?” https://t.co/DvJnA1f9MP https://t.co/DvJnA1f9MP - view on twitter
Mashup Score:13
STATThe unexpected alliance lobbying for Medicare to pay for new obesity drugs - 2 weeks
Mashup Score:13
An unexpected alliance is lobbying for Medicare to pay for new obesity...
-
Did not realize this: “Medicare is prohibited by law from paying…Lawmakers banned coverage of obesity drugs when program’s prescription drug benefit was created in 2003,…” Needs to change as obesity is THE driver for most diseases today (CVD, cancer) https://t.co/MLiWXELnZx - view on twitter
Mashup Score:5
Timmerman ReportBiotech Needs to Get Back to Work in Person. Now. – TimmermanReport.com - 2 weeks
Mashup Score:5
Companies at the frontiers of science and medicine, developing new therapies for patients, are working on one of the most challenging endeavors known to...
-
Nice read @JMaraganore https://t.co/Eimi6rODtV - view on twitter
Buoyed by recent approvals, the field faces a pivotal year that’s likely to bring new treatments as well as more...
-
RT @BentheFidler: 5 questions facing gene therapy in 2023 https://t.co/zvgrR8isTA by @NedPagliarulo #GeneTherapy $BLUE $VERV $AVRO $QURE $B… - view on twitter
More coverage:
#genetherapy
This genetic association study evaluates the association of protein-truncating variants in APOB and PCSK9 with low-density lipoprotein (LDL) cholesterol levels and coronary heart...
Paper in @JAMACardio https://t.co/pgNyxDnk17 - view on twitter